PR Newswire (US) — Real Estate·KR·Mon, 24 Aug 2026 05:21:00 UTC

GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan

- Secures approval for 'Hunterase IV' in India and both 'Hunterase IV & ICV' in Taiwan, accelerating expansion into the Asian rare disease market YONGIN, South Korea, Aug. 24, 2026 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global pharmaceutical company based in South Korea,...

Open original ↗Open in cockpit

Read releases like this the second they cross the wire.

1,400+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 72-hour free trial, no card required.

Start the free trial →

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.

PPN Source →

Shared via PPN World — real-time press release intelligence.